Thursday, June 8, 2023 at 12:00 AM
This grand round has already taken place.
Description
Advances in technology have made sequencing DNA and RNA from formalin fixed tissue possible and increasingly accessible and affordable. These sequencing technologies can now provide a new lens for evaluation of pathologic tissue specimens. Through these new lens, there is an opportunity for new insights which can be translated into new diagnostic clinical tests, improved prognostication and prediction of treatment response. This presentation describes experiences and results surrounding the transformative effect of novel omics technologies in diagnostic GI pathology.
Dates and Times
Start: 6/8/2023 12:00 AM
End: 6/8/2023 1:00 PM
Objectives
• Describe the molecular basis of multiple GI/liver tumors
• Outline the importance of novel biomarker discovery in GI/Liver and Anatomic pathology
• Discuss mechanisms of novel biomarker discovery in Anatomic Pathology
Speakers
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Jessica Mattera
Department: Pathology Department
Phone: (631) 444-3000
Email: jessica.mattera2@stonybrookmedicine.edu